Bulletin
Investor Alert

Regeneron Pharmaceuticals Inc.

NAS: REGN

GO
/marketstate/country/us

After Hours

/zigman2/quotes/203149337/composite

$

615.00

Change

+2.65 +0.43%

Volume

Volume 23,729

Aug 12, 2020, 7:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/203149337/composite

Today's close

$ 598.86

$ 612.35

Change

+13.49 +2.25%

Day low

Day high

$599.90

$617.00

Open
Open: 599.90

52 week low

52 week high

$271.37

$664.64

Open

Market cap

$63.71B

Average volume

884,600

P/E ratio

23.71

Rev. per Employee

$906,865

EPS

25.83

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/regn

MarketWatch News on REGN

  1. Dow Gains as Stocks Look Past Dismal Jobs Data

    12:55 p.m. Aug. 5, 2020

    - Ben Levisohn

  2. Regeneron Stock Climbs as Earnings Come in Strong

    9:02 a.m. Aug. 5, 2020

    - Josh Nathan-Kazis

  3. Regeneron shares jump 2.7% premarket

    6:43 a.m. Aug. 5, 2020

    - Ciara Linnane

  4. Regeneron expects fully-recruited clinical trials to remain intact despite pandemic

    6:41 a.m. Aug. 5, 2020

    - Ciara Linnane

  5. Regeneron Q2 revenue $1.952 bln vs. $1.578 bln; FactSet consensus $1.726 bln

    6:40 a.m. Aug. 5, 2020

    - Ciara Linnane

  6. Regeneron Q2 adj. EPS $7.16; FactSet consensus $5.91

    6:40 a.m. Aug. 5, 2020

    - Ciara Linnane

  7. Regeneron Q2 EPS $7.61 vs. $1.68

    6:40 a.m. Aug. 5, 2020

    - Ciara Linnane

  8. Regeneron’s Covid-19 Antibody Looks Promising in Animal Test

    11:24 a.m. Aug. 4, 2020

    - Josh Nathan-Kazis

  9. Buy Merck for Its Unappreciated Pipeline, Says Goldman

    10:47 a.m. Aug. 3, 2020

    - Bill Alpert

  10. Eli Lilly Testing a Covid-19 Antibody Drug in Nursing Homes

    9:16 a.m. Aug. 3, 2020

    - Josh Nathan-Kazis

  11. Roche's rheumatoid arthritis drug fails in COVID-19 trial

    7:24 a.m. July 29, 2020

    - Jaimy Lee

  12. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/regn

Other News on REGN

  1. Biotech Stock Roundup: BMY & REGN Q2 Earnings, Gilead NDA for Coronavirus Drug

    12:23 p.m. Today

    - Zacks.com

  2. FDA accepts Regeneron application for evinacumab for inherited cholesterol disorder

    7:18 a.m. Today

    - Seeking Alpha

  3. Drug/Biotech Stock Q2 Earnings Due on Aug 11: VIR and AUPH

    11:28 a.m. Aug. 10, 2020

    - Zacks.com

  4. Regeneron (REGN) Gets a Hold Rating from Cowen & Co.

    5:08 a.m. Aug. 10, 2020

    - SmarterAnalyst

  5. Biotech's Q2:  Lots Of Candidates That May Deliver Alpha

    12:29 p.m. Aug. 9, 2020

    - Seeking Alpha

  6. Regeneron Pharma prices senior unsecured notes offering

    4:26 p.m. Aug. 7, 2020

    - Seeking Alpha

  7. Alnylam Managing Through Covid-19 Challenges And Executing Well

    12:34 p.m. Aug. 7, 2020

    - Seeking Alpha

  8. Morgan Stanley Maintains a Hold Rating on Regeneron (REGN)

    11:55 a.m. Aug. 6, 2020

    - SmarterAnalyst

  9. Regeneron (REGN) Receives a Hold from RBC Capital

    11:39 a.m. Aug. 6, 2020

    - SmarterAnalyst

  10. 10-Q: ALNYLAM PHARMACEUTICALS, INC.

    8:20 a.m. Aug. 6, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  11. Merck Stock Remains a Dull Biotech Play Despite Earnings Success

    12:01 p.m. Aug. 5, 2020

    - InvestorPlace.com

  12. Loading more headlines...
/news/pressrelease/company/us/regn

Press Releases on REGN

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.